Development of an immunogenic cell death-related lncRNAs signature for prognostic risk assessment in gastric cancer

被引:0
作者
Li, Wen [1 ]
Ding, Fan [2 ]
Zhang, Jie [1 ]
机构
[1] Nantong Univ, Sch Med, Dept Immunol, 19 Qixiu Rd, Nantong 226000, Peoples R China
[2] Nantong Univ, Peoples Hosp Danyang, Danyang Hosp, Dept Med Adm, Zhenjiang, Peoples R China
关键词
Gastric cancer (GC); long non-coding RNA (lncRNA); immunogenic cell death (ICD); immune infiltration; immunotherapy; DENDRITIC CELLS; T-CELL; TIM-3; BIOMARKER; SURVIVAL; CALRETICULIN; CHEMOTHERAPY; EXPOSURE; PD-1;
D O I
10.21037/tcr-24-344
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Immunogenic cell death (ICD) is a functionally specialized form of apoptosis induced by endoplasmic reticulum (ER) stress and is associated with a variety of cancers, including gastric cancer (GC). In recent years, long non-coding RNAs (lncRNAs) have been shown to be important mediators in the regulation of ICD. However, the specific role and prognostic value of ICD-related lncRNAs in GC remain unclear. This study aims to develop an ICD-related lncRNAs signature for prognostic risk assessment in GC. Methods: The ICD-related lncRNAs signature (ICDlncSig) of GC was constructed by univariate Cox regression analysis, least absolute shrinkage, and selection operator (LASSO) regression model and multivariate Cox regression analysis, and the signature was correlated with immune infiltration. The potential response of GC patients to immunotherapy was predicted by the tumor immune dysfunction and rejection (TIDE) algorithm. In vitro functional experiments were conducted to assess the impact of lncRNAs on the proliferation, migration, and invasion capabilities of GC cells. Results: We constructed a novel ICDlncSig and found that this signature could be used as a prognostic risk model to predict survival of GC patients by validating it in the training cohort, testing cohort and entire cohort. The robust predictive power of the signature was demonstrated by building a Nomogram based on ICDlncSig scores and clinical characteristics. Furthermore, immune cell subpopulations, expression of immune checkpoint genes, and response to chemotherapy and immunotherapy differed significantly between the high- and low-risk groups. The in vitro functional experiments revealed that AP002954.1 and AP000695.1 can promote the proliferation, migration, and invasion of GC cells. Conclusions: In conclusion, our ICDlncSig model has significant predictive value for the prognosis of GC patients and may provide clinical guidance for individualized immunotherapy.
引用
收藏
页码:4420 / 4440
页数:26
相关论文
共 63 条
[1]   Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective [J].
Abdi, Esmat ;
Latifi-Navid, Saeid ;
Abedi Sarvestani, Fatemeh ;
Esmailnejad, Mohammad Hassan .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (08) :685-699
[2]   Targeting immunogenic cell death in cancer [J].
Ahmed, Asma ;
Tait, Stephen W. G. .
MOLECULAR ONCOLOGY, 2020, 14 (12) :2994-3006
[3]   Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) [J].
Allemani, Claudia ;
Weir, Hannah K. ;
Carreira, Helena ;
Harewood, Rhea ;
Spika, Devon ;
Wang, Xiao-Si ;
Bannon, Finian ;
Ahn, Jane V. ;
Johnson, Christopher J. ;
Bonaventure, Audrey ;
Marcos-Gragera, Rafael ;
Stiller, Charles ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Ogunbiyi, Olufemi J. ;
Rachet, Bernard ;
Soeberg, Matthew J. ;
You, Hui ;
Matsuda, Tomohiro ;
Bielska-Lasota, Magdalena ;
Storm, Hans ;
Tucker, Thomas C. ;
Coleman, Michel P. .
LANCET, 2015, 385 (9972) :977-1010
[4]   Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future [J].
Alzeibak, Razan ;
Mishchenko, Tatiana A. ;
Shilyagina, Natalia Y. ;
Balalaeva, Irina V. ;
Vedunova, Maria V. ;
Krysko, Dmitri V. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)
[6]  
Apetoh Lionel, 2007, Cancer Genomics & Proteomics, V4, P65
[7]   A Novel Prognostic Ferroptosis-Related Long Noncoding RNA Signature in Clear Cell Renal Cell Carcinoma [J].
Bai, Zhixun ;
Zhao, Yongchao ;
Yang, Xiaomin ;
Wang, Linglu ;
Yin, Xianhua ;
Chen, Yue ;
Lu, Jing .
JOURNAL OF ONCOLOGY, 2022, 2022
[8]   The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation [J].
Bardhan, Kankana ;
Anagnostou, Theodora ;
Boussiotis, Vassiliki A. .
FRONTIERS IN IMMUNOLOGY, 2016, 7
[9]   Impact of a novel phosphoinositol-3 kinase inhibitor in preventing mitochondrial DNA damage and damage-associated molecular pattern accumulation: Results from the Biochronicity Project [J].
Black, George Edward ;
Sokol, Kyle K. ;
Moe, Donald M. ;
Simmons, Jon D. ;
Muscat, David ;
Pastukh, Victor ;
Capley, Gina ;
Gorodnya, Olena ;
Ruchko, Mykhaylo ;
Roth, Mark B. ;
Gillespie, Mark ;
Martin, Matthew J. .
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2017, 83 (04) :683-689
[10]   Abscopal Effect After Palliative Radiotherapy in a Patient with a Gastric Adenocarcinoma Disseminated to Retroperitoneal Space: Case Report from a Latin American Reference Center and Review of the Literature [J].
Bonilla, Carlos E. ;
Esguerra, Jose ;
Diaz, Sara Mendoza ;
Alvarez, Angelina ;
Morales, Laura .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (11)